A detailed history of All Terrain Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, All Terrain Financial Advisors, LLC holds 300 shares of LLY stock, worth $230,328. This represents 0.1% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$230,328
Previous $271,000 2.21%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $217,461 - $272,712
300 New
300 $271,000
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $246,480 - $319,080
-1,500 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $195,690 - $258,945
1,500 New
1,500 $253,000
Q2 2020

Jul 28, 2020

SELL
$136.42 - $164.18 $284,708 - $342,643
-2,087 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $179,189 - $223,955
2,087 New
2,087 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track All Terrain Financial Advisors, LLC Portfolio

Follow All Terrain Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.